Companhia Brasileira De Distribuicao
CBDBY
$0.37
$0.000.00%
| Weiss Ratings | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.77 | |||
| Price History | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.73% | |||
| 30-Day Total Return | -9.76% | |||
| 60-Day Total Return | 5.11% | |||
| 90-Day Total Return | -26.00% | |||
| Year to Date Total Return | 2.78% | |||
| 1-Year Total Return | -49.25% | |||
| 2-Year Total Return | -59.03% | |||
| 3-Year Total Return | -72.97% | |||
| 5-Year Total Return | -66.67% | |||
| 52-Week High % Change | -50.34% | |||
| 52-Week Low % Change | 23.33% | |||
| Price | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.75 | |||
| 52-Week Low Price | $0.30 | |||
| 52-Week Low Price (Date) | Apr 19, 2024 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 211.04M | |||
| Enterprise Value | 1.23B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.94 | |||
| Earnings Per Share Growth | -58.30% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.04 | |||
| Price/Book (Q) | 0.25 | |||
| Enterprise Value/Revenue (TTM) | 0.34 | |||
| Price | $0.37 | |||
| Enterprise Value/EBITDA (TTM) | 10.88 | |||
| Enterprise Value/EBIT | 34.91 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 431.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 55 11 3886 0421 | |||
| Address | Avenida Brigadeiro Luiz Antonio, 3142 São Paulo, SP 01402-901 | |||
| Website | www.gpari.com.br | |||
| Country | Brazil | |||
| Year Founded | 1948 | |||
| Profitability | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.96% | |||
| Profit Margin | -8.58% | |||
| Management Effectiveness | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.54% | |||
| Return on Equity | -- | |||
| Income Statement | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.66B | |||
| Total Revenue (TTM) | 3.66B | |||
| Revenue Per Share | $8.49 | |||
| Gross Profit (TTM) | 990.91M | |||
| EBITDA (TTM) | 113.08M | |||
| EBIT (TTM) | 35.24M | |||
| Net Income (TTM) | -314.33M | |||
| Net Income Avl. to Common (TTM) | -314.33M | |||
| Total Revenue Growth (Q YOY) | -9.56% | |||
| Earnings Growth (Q YOY) | -127.57% | |||
| EPS Diluted (TTM) | -0.94 | |||
| EPS Diluted Growth (Q YOY) | 86.77% | |||
| Balance Sheet | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 423.13M | |||
| Cash Per Share (Q) | $0.98 | |||
| Total Current Assets (Q) | 1.08B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 740.84M | |||
| Current Ratio (Q) | 0.933 | |||
| Book Value Per Share (Q) | $1.51 | |||
| Total Assets (Q) | 3.61B | |||
| Total Current Liabilities (Q) | 1.16B | |||
| Total Debt (Q) | 1.66B | |||
| Total Liabilities (Q) | 2.87B | |||
| Total Common Equity (Q) | 739.37M | |||
| Cash Flow | CBDBY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 83.90M | |||
| Cash from Financing (TTM) | -496.93M | |||
| Net Change in Cash (TTM) | -142.01M | |||
| Levered Free Cash Flow (TTM) | 147.18M | |||
| Cash from Operations (TTM) | 271.02M | |||
